Ceva Animal Health has highlighted a new meta-analysis1 which, according to the company, reveals that there is a significant (P< 0.001) association between the use of pharmacotherapy (fluoxetine and clomipramine) or pheromonatherapy (Feliway) and reduction or elimination of feline urine marking.
Ceva says this is the first time a meta-analysis technique has been used to evaluate the efficacy of interventions in veterinary behavioural medicine; the study assessed all published papers covering treatments for feline urine spraying. Ten studies in nine publications were analysed, despite their different study designs. In order to carry out the meta-analysis, the papers were rated according to importance and a 'placebo-effect' was calculated. Primary and secondary outcomes were also identified, with the primary outcome being the 'number of cats that either ceased or reduced spraying by at least 90%' and the secondary outcome being 'the number of cats that reduce spraying from baseline levels'.
Information is available by calling Lucy Brett at CEVA Animal Health on 01494 781510.
1. A meta-analysis of studies of treatments for feline urine spraying. Daniel S Mills, Sarah E Redgate, Gary M Landsberg. PLos ONE, April 2011, Volume 6, Issue 4
Animal Friends Insurance (AFI), a not-for-profit pet insurance business, has a High Court injunction which paves the way for its customers to make a smooth transition from the company's previous underwriters, Equine and Livestock Insurance Company (E&L), to Red Sands Insurance Company (Europe) Limited.
Equine and Livestock terminated their underwriting agreement with AFI in February 2008, citing unprofitablility of the book for them as the reason.
Negotiations over the transfer of the book to Red Sands Insurance Company (Europe) Limited foundered when E&L demanded £750,000 from AFI for the transfer and for their agreement not to solicit AFI customers.
Following legal advice AFI wrote to its customers offering to renew policies with Red Sands. This spawned letters to AFI customers from E&L which caused great confusion amongst customers as to what was happening with their insurance. The letters also offered first a 10% then a 20% discount to tempt AFI customers to renew with E&L and not to stay with AFI.
AFI therefore applied for an emergency injunction to prevent E&L making further contact with AFI customers (except in agreed situations, notably claims), to stop the escalating confusion and also to require them to acknowledge renewals advised to them by AFI into Red Sands and not to take further payments on those insurances. The application was successful.
Elaine Fairfax, Managing Director and Founder of AFI said: "I am delighted at the Court ruling. It has resolved the terrible confusion that followed E&L's letters to our customers. Unfortunately we know that some customers said they would renew with E&L thinking they were staying with us! Now we can simply renew our customers' policies with our new underwriters as we had originally intended to do at no inconvenience to them as they need do nothing if they want to stay with Animal Friends. They will enjoy exactly the same policy terms and premiums as before and our underwriters will even take on existing ongoing conditions where a policyholder has lifetime cover."
She added: "Although this has been a horrible experience we are delighted to have new underwriters as they have given us authority to handle everything in-house. For vets this means that Animal Friends will now be handling claims at our Wiltshire H.Q. We have a bespoke pet claims software systems and veterinary nurse staff to give the best possible service. We have the facility to pay claims swiftly direct into a customer's bank account or direct to a vet. It is also exciting that we shall be able to draw on Hollard's* international pet insurance experience to introduce some unique new products and ideas into the UK pet insurance market in the near future."
Veterinary surgeon Andrew Reeder, Director of the Stonehenge Veterinary Hospital, in Durrington, near Salisbury, was the lucky winner of a Sony Pocket e-Reader in the Royal College of Veterinary Surgeons' prize draw at the London Vet Show in November.
The competition was mounted to launch an online quiz to test members' knowledge of the Guide to Professional Conduct. All those who completed the quiz on the RCVS stand at the event were entered into a prize draw: the RCVS would like to stress that it was a random draw, in spite of the serendipity of Andrew's surname!
"This is brilliant, I so rarely win anything!" said Andrew. "I'd recommend that all RCVS members should have a go at the quiz - it's quick, easy to complete and certainly makes you think."
Over 600 people have tackled the quiz so far. Those who fancy testing their knowledge of the Guide should visit www.rcvs.org.uk/guidequiz. The quiz is anonymous, but the College will be collating data to help focus future communications activities and see where extra guidance may be required. On completion of the quiz, it is possible to review answers and view the relevant section of the online Guide.
Her Royal Highness, the Princess Royal opened a new ward for canine cancer patients at the University of Edinburgh's Royal (Dick) School of Veterinary Studies Hospital for Small Animals last week.
The Kennel Club Charitable Trust provided £30,000 towards the 26-kennel ward, which is specifically designed to provide recuperative care and comfortable kennelling facilities for dogs at the University's Hospital for Small Animals.
The facilities the new dog ward provides will complement the School's £3 million Riddell-Swan Veterinary Cancer Centre, which opened last year. The cancer care centre houses state-of-the-art equipment including a computerised tomography (CT) scanner and a linear accelerator that can provide radiotherapy treatment.
Caroline Kisko, Secretary of the Kennel Club, said: "The Kennel Club Charitable Trust is extremely pleased that the money it has given to the University of Edinburgh has helped to ensure that its Canine Cancer Care unit could be built.
"The Trust has supported the groundbreaking research being conducted by the University, which is helping to improve our ability to diagnose and treat cancer in dogs, for some time. The Cancer Care Unit will help in a different way, by providing post-treatment and after care for dogs that have been through cancer therapy.
"People love their dogs as a member of their family, so this is a vital part of the care process. It is comforting for them to know that there are comfortable kenneling facilities where their dogs will receive the recuperative care that they need, as well as the potentially life-saving treatment.
"The Charitable Trust has given millions of pounds to projects which help to improve the health and welfare of dogs across the UK. This unit has established the University's place as a leader in conducting not only lifesaving but also life enhancing work for dogs, and the Trust exists precisely to help projects such as this realise their goals."
The canine oncology support ward replaces the old feline ward, and the cats have been moved to a new ward further away from the dogs to help prevent cats from becoming stressed by the noise of barking.
Professor Elaine Watson, Head of the Royal (Dick) School of Veterinary Studies said: "The dog ward, along with our new feline ward enhances the facilities for animals receiving treatment at the School's Hospital for Small Animals and we are very appreciative of the tremendous support from the Kennel Club Charitable Trust."
The introduction of the new Level 3 Diploma in Veterinary Nursing has seen an increase in numbers of both students and training practices, according to statistics released today by the RCVS.
Since January, the RCVS has approved over 30 more Training and Auxiliary Training Practices, bringing to a total of 1,559 the number of practices approved for veterinary nurse (VN) training. Scope for practices to train student VNs is increased through the emphasis on Auxiliary Training Practices (aTPs), an option for practices without the full facilities or caseload needed for student training. Students at aTPs complete their in-practice training at other aTPs or full Training Practices. Of the 31 new practices approved since January for student training, eight are aTPs.
The number of VN students enrolling with the RCVS has also increased, with almost double the number enrolling in January 2011, compared with January 2010. There were a total of 1,168 student enrolments in the 12 months from 1 February 2010, compared with 1,121 enrolments in the same period from 1 February 2009.
Libby Earle, Head of the RCVS Veterinary Nursing Department said: "The Level 3 Diploma has been in place for little more than six months, yet VN student numbers are already up. This bodes well for the supply of qualified, competent registered veterinary nurses demanded by veterinary practices, and for those keen to enter the veterinary nursing profession."
The qualification was introduced when the government abolished the National Vocational Qualification (NVQ) system last summer, forcing a change in the vocational qualifications for VNs. The resulting Level 3 Diploma is designed to better meet the needs of practices, colleges, and students themselves.
Dechra Veterinary Products has launched www.canine-cushings.co.uk, a new website for owners of dogs with Cushing’s syndrome, to support the advice given by their veterinary surgeon.
The new site contains information and resources designed to support dog owners whose pets have been prescribed Vetoryl. It looks at symptoms, diagnosis and treatment options, and owners can register for interactive treatment log book.
Craig Sankey, Brand Manager at Dechra Veterinary Products, said: "Diagnosis can be worrying for owners and the aim of the website is to help increase knowledge surrounding Cushing’s syndrome.
"The interactive treatment log book can be used by owners to chart progress and provide reassurance about how their dog is responding to Vetoryl therapy."
606 veterinary professionals took part in the research, mostly Practice Managers (34%), Head Nurses (23%) Head Vets (22%) and Administrators (9%)
Of all the respondents, which included those newly-promoted, early career, middle management, senior management and principal leaders, 33% of respondents described their competence as ‘intermediate’, 47% as intermediate, 18% as 'advanced' and only 2% as ‘expert’.
The VMG says its report raises fresh concerns about the preparedness of those tasked with steering veterinary teams through an increasingly complex and demanding landscape.
Rebecca Robinson MRCVS (pictured), incoming VMG President, said: “This year’s report again highlights the urgent need to equip both current and future leaders with the skills and support they need to thrive.
"While there are encouraging signs of progress, we must act with greater urgency as a profession to embed leadership development at every level - especially for those stepping into leadership roles for the first time."
“We encourage all members of the veterinary team to invest in developing their communication and influencing skills well before they take on leadership roles.
"Gaining experience in these areas early on will better prepare them for the demands of leadership and empower them to take charge of their career journeys.
“We also call on employers to make leadership development a priority."
The VMG offers a range of Institute of Leadership and Management-accredited qualifications – the Award, Certificate and Diploma in Veterinary Leadership and Management.
https://vetmg.com/qualifications/cvlm/
The Elekta Infinity linear accelerator is the only one of its kind for pets in England.
CVS says it allowing the centre to offer “cutting edge” image-guided radiation treatments for cancer in cats and dogs – meaning fewer, shorter sessions, fewer side effects and the best possible chance of improved outcomes for the animal.
Delphine Holopherne-Doran, Clinical Director at Bristol Vet Specialists, said: “Our new hospital is now at the forefront of cancer care in animals.
"We have invested in this state-of-the-art technology to bring cancer treatment in pets to the next level.
“Our unique linear accelerator allows us to offer advanced image-guided treatments - for example intensity-modulated or stereotactic radiation therapy.
"The advantage of these treatments is that high dose rates of focused beams are delivered with high precision over a shortened treatment course, with greater safety for the patient’s healthy tissue.
“It has now drawn many tumours into the realm of treatability, it is improving the quality of life for patients, and it is making it easier for owners to manage their pet’s treatment and aftercare.”
Still, the installation of the linear accelerator will probably have cost the same again, and then you've got the running costs.
That's not an inconsiderable cost per patient.
The poster can be downloaded free of charge from NOAH’s Pet Health Info website and a limited number are available from NOAH free of charge on a first-come, first-served basis.
Featuring pet photos from NOAH’s 'Happy healthy pets' project gallery, the planner contains independent seasonal expert tips and advice for pets: from exercise, diet and healthcare to keeping them safe and comfortable in different weather conditions.
Over the coming months, the campaign will continue to roll out tips and expert advice from NOAH and partners, tailored web content, as well as press and social media activity.
The poster is part of ’I Heart My Pet’ campaign, now in its third year, which includes the Happy, Healthy Pets Project – an interactive online gallery, where pet owners have already uploaded more than 2000 images of happy, healthy pets.
NOAH Chief Executive, Dawn Howard said: "We are thrilled that these three great animal welfare charities have joined forces with NOAH to help extend the reach of our collective networks on this project, with the ultimate objective of improving the health of the UK’s pets.
"PDSA’s sterling work through its PAW Report, highlighting areas where we need to focus to improve pet welfare made them an obvious choice and we are delighted to be working with them on this. Cats Protection helps thousands of cats every year and provides invaluable information on cat care. We hope that by working together we’ll be able to assist them in helping many more.
RWAF’s work on educating owners about the responsibility involved in taking on rabbits as pets, through campaigns such as Rabbit Awareness Week, is of vital importance and we look forward to working closely with them to spread the word even further."
The Bella Moss Foundation (BMF) has launched a free practice hygiene audit tool.
The BMF Practice Hygiene Self Audit is a web-based assessment tool that allows staff to monitor cleanliness across the practice – from theatre and prep rooms to laundry and waiting rooms.
The tick sheet format allows staff to rate the hygiene protocols in each area, resulting in a room-by-room percentage hygiene score, as well as an overall contamination risk score.
The tool was developed by vet and RCVS Practice Standards Scheme (PSS) expert Pam Mosedale and VN lecturer Louise O'Dwyer, along with Edinburgh academic Tim Nuttall and Chris Laurence.
Pam said: "Given the relaunch of the PSS later in the year, which will include new modules on infection control, the BMF audit tool is especially timely.
"We hope that people will try the audit tool and it will lead them to have more of a team discussion about hygiene routines and protocols in practice. We know some areas get more attention than others - for example, how often do things like the toys in the waiting area really get cleaned?
“By using the audit, staff will easily be able to see what rooms/areas might need a bit more cleaning.
She added: "It's a simple no-frills tool but the whole idea is for it to be helpful and easy to use, so more practices are encouraged to have regular quantifiable monitoring systems in place to keep an eye on their hygiene protocols."
Co-creator Louise O'Dwyer said: “The BMF Practice Hygiene Self Audit will help ensure often overlooked aspects of cleaning and infection control are considered and implemented.
“It needs to be embraced by all members of staff, from non-clinical staff through to veterinary surgeons, as every individual has the potential to make an impact within their practice by taking action on infection control.”
To test the tool and see how clean your practice is, go to: www.thebellamossfoundation.com/practice-hygiene-self-audit
Key Note Ltd, has published Pet Insurance 2015, a report into the state of the UK pet insurance market which forecasts that premiums will rise by 46.7% by 2019.
The report notes that the percentage of adults in Great Britain owning at least one dog has increased by 2.1 percentage points over the past 5 years, and the percentage owning at least one cat is 2.5 percentage points higher than it was 5 years ago. Yet despite growth in the pet population, the increase in the volume of pet insurance policies (23.6% between 2010 and 2014) has been far exceeded by the increase in the value of premiums written (40.7%).
Key Note says claims inflation has been a major factor in rising premiums; despite gross written premiums for cats, dogs and other pets increasing by 13.3% between 2013 and 2014 alone, the cost of claims for the same animals rose by 14.7% over the same period, over and above the premium increases seen.
According to the company, rising claims are largely down to the increasing cost of veterinary treatment — as advances in pet medicine increase apace with those in human medicine, treating pets is getting more costly. Not only this, but other factors, such as the rise in overweight or obese pets and even antibiotic-resistant bacteria, both common problems in the human health service, are also pushing up the costs of veterinary treatment.
In other general insurance markets, most notably motor insurance, which price comparison websites (PCWs) were initially set up to focus on, competition exerts a major downward pressure on premiums. However, the report says this is not always the case in the pet insurance market. This is because it can be difficult for those who have already claimed on pet insurance policies to switch insurers; the result of doing so is often that the condition the pet has previously been treated for is classed as ‘pre-existing’ in the new policy and therefore it, and related conditions, will not be covered under the new policy. This could leave pet owners liable to pay for veterinary treatment in full.
The situation has been further exacerbated by the high-profile withdrawal of a number of underwriters from the pet insurance market. The nature of the pet insurance market, though at first seeming diverse, actually involves a relatively limited pool of underwriters behind the numerous brands available. The report details how just four underwriters between them either underwrite or, at the very least, arrange and administer the pet insurance policies of 27 of the foremost brands in the pet insurance market.
Key Note forecasts that although insurance companies will see an increase in the volume of pets insured, this will not compensate for the relentless increase in the cost of claims which will be largely responsible for driving the cost of pet insurance up 46.7% by 2019.
The findings of a Canine Vector Borne Disease (CVBD) prevention field study, published in Veterinary Parasitology today, have demonstrated the efficacy of Advantix in repelling ticks and sandflies, thus reducing the risk of potentially deadly diseases.
The study, conducted over two years by a team headed by Professor Domenico Otranto of the Faculty of Veterinary Medicine (Universitá degli Studi di Bari) Italy, with diagnostic support from a team led by Dr. Edward Breitschwerdt at the North Carolina State University, USA, found that dogs treated regularly with Advantix spot-on had a greater than 90% reduction in CVBD cases, including a 100% reduction in new cases of potentially deadly leishmaniosis and a 94.6% decrease in ehrlichiosis.
The study also found that Advantix provided 97.9% protection against tick infestation, compared to untreated dogs, where 100% were infested at the peak of the season. The level of protection offered by Advantix was apparently all the more notable because of particularly large numbers of ticks and sand flies and high prevalence of associated diseases like leishmaniosis or babesiosis in the area of the study.
Prof. Otranto said: "Our study shows the importance of protecting dogs with an effective treatment that repels as well as kills parasites like ticks and sand flies. Despite the high challenge faced by the dogs in our study, nearly all our treated dogs remained free from ticks throughout most of the study, and more than 90% remained free from CVBDs for the whole study time.
"Because we included naïve sentinel beagles in the study, we were also able to model what would happen to dogs travelling to areas where CVBDs are present. We found that by the end of the study, only the Advantix-treated beagles remained protected from infection, while 80% of the untreated beagles were infected with a CVBD. This demonstrates the very real need to protect dogs that are travelling to endemic areas."
According to Bayer, the study showed some interesting results with dogs that were positive with CVBDs when they entered the study. Of these, half of those treated with Advantix were negative for CVBDs at the end of treatment, compared with only 13% of untreated dogs. This suggests the potential for natural clearance of CVBDs if a repellent treatment is used to prevent new transmissions.
Bayer says the study was extremely comprehensive, studying both indigenous and introduced naïve puppies, monitoring for several CVBDs and working with Dr. Breitschwerdt's team in the USA to use highly sensitive molecular testing techniques to ensure optimal diagnostic accuracy. Dr. Breitschwerdt said: "This is the most comprehensive study, to my knowledge, ever conducted testing the efficacy of a repellent ectoparasiticide to prevent the transmission of a spectrum of CVBDs in young dogs."
Leading parasitologist Dr. Luis Cardoso of the University of Trás-os-Montes e Alto Douro, Portugal said: "Thanks to this study we can see just how effective a treatment that repels as well as kills can be."
CEVA Animal Health has published a trial which, according to the company, shows that horses suffering lameness caused by bone spavin can show marked improvement following treatment with a Tiludronate infusion, in combination with controlled exercise.
Bone spavin is a chronic aseptic osteoarthritis of the distal tarsal joints which, says CEVA, is considered to be one of the most common forms of hindlimb lameness in the horse.
The double-blind, multicentric, placebo-controlled trials were carried out on a total of 108 pleasure horses, show jumpers and eventers of a variety of sizes and breeds, all of which had been clinically diagnosed with bone spavin. The horses were rigorously selected, having to show clinical signs of spontaneous lameness of at least six weeks but less than a year's duration and had to be in daily exercise. Horses suffering proximal suspensory desmitis were excluded.
Horses were defined as suffering from bone spavin if they displayed a chronic hindlimb lameness which improved with distal tarsal joint analgesia and showed radiographic evidence of bony changes associated with bone spavin in the distal tarsal joints. The horses were treated at day zero with a single Tiludronate infusion or a placebo and reassessed 60 days later after a period of controlled exercise.
Eighty seven horses completed the trials, comprising 42 Tiludronate treated horses and 45 placebo cases. By day 60 approximately 60% of the Tiludronate treated horses had improved in lameness by two grades or more, scored on a ten point system.
Horses with bone spavin experience abnormal bone remodeling changes, occasionally with excessive bone resorption in the tarsal bones. Tiludronate works by regulating this bone remodeling through a decrease in the resorptive process, slowing down the degradation of the bone structure when the condition is progressing and alleviating the pain associated with abnormal bone lysis.
CEVA has recently produced a leaflet specifically to help horse owners to understand the diagnosis and treatment of bone spavin. For copies of this leaflet and CEVA's comprehensive veterinary brochure on the product please contact CEVA Animal Health on 01494 781510 or visit the website at http://www.tildren.com/
Tiludronate infusion in the treatment of bone spavin: A double blind placebo-controlled trial
Reference M. R. GOUGH*, D. THIBAUD† and R. K. W. SMITH‡ (*CEVA Animal Health, Bucks, UK; †CEVA Animal Health USA, Kansas, USA; and ‡Department of Veterinary Clinical Sciences, The Royal Veterinary College, University of London, UK). Equine vet. J. (2010) 42 (5) 381-387 doi: 10.1111/j.2042-3306.2010.00120.x
Dechra Veterinary Products has launched a webcast about feline hyperthyoidism, given by Tim Williams MA VetMB MRCVS from the Feline Research Group at the Royal Veterinary College.
During the ten minute webcast, entitled: 'The highs and lows of feline hyperthyroidism', Tim presents new evidence that overdosing hyperthyroid patients can lead to iatrogenic hypothyroidism, making them more likely to develop azotaemia and consequently have a shorter survival time. He also discusses the diagnosis and potential consequences of iatrogenic hypothyroidism based on recent research conducted at the Feline Research Group, and provides a summary of suggested treatment protocols. Tim said: "I hope the webcast helps veterinary staff optimise their treatment of hyperthyroid cats in practice and avoid a one size fits all approach".
Dechra says that research from 400 first opinion practices has shown that hyperthyroidism is the most commonly diagnosed feline endocrinopathy, with an annual incidence of 6% in cats over nine years old.
Tim's webcast is the latest in a series of online educational materials on endocrinology launched by Dechra as part of its Dechra Academy training suite.The webcast is available at http://www.dechra.co.uk/hyperthyroidism
Boehringer Ingelheim has announced that its 'Talk About Laminitis' campaign will run from Mid March until the end of June.
Last year, the initiative saw over 9000 horses and ponies tested for PPID through its free ACTH test scheme. This year, to build on this success and support the testing of even more animals, the company has announced a high impact, co-ordinated campaign to drive awareness that up to 90% of laminitis cases may have an underlying endocrine cause1,2.
Once again, Boehringer is urging veterinary surgeons to carry out free ACTH blood tests on laminitic or foot-sore horses as part of the campaign, which is backed by Redwings, The British Horse Society and World Horse Welfare.
Professor Andy Durham from the Liphook Equine Hospital, where the ACTH tests are performed, said: "We are learning so much from these tests. For example, we are now recognising PPID routinely in laminitic horses and ponies as young as 10 years old, and in the spring when we might expect to see more EMS cases, where veterinary surgeons have also tested for PPID we are seeing both abnormally elevated ACTH and insulin. Unless the PPID is addressed, horses will continue to be at risk of painful recurrent laminitic episodes which is a significant welfare issue to the horse and extremely frustrating for owners."
To participate in the scheme, veterinary surgeons and horse owners can download ACTH blood test vouchers from www.talkaboutlaminitis.co.uk. Attach the voucher to the ACTH sample submission form and the ACTH laboratory fees will not be charged.
Lee Hackett from The British Horse Society said: "Without the 'Talk About Laminitis' initiative and the support of Boehringer Ingelheim, literally thousands of horses may not be receiving the appropriate treatment and management for their laminitis to help prevent recurrence. We hope as many veterinary surgeons as possible get involved this year to continue this welfare success."
To ensure that horse owners are fully aware of the initiative, a PR and advertising campaign in the equine consumer media will start in March. The ad campaign includes an infomercial on Horse & Country TV (SKY Channel 280), with viewer numbers in excess of 450,000 per month.
There will also be a live online broadcast for horse owners on endocrinopathic laminitis presented by David Rendle BVSc MVM CertEM(IntMed) DipECEIM MRCVS, from the Liphook Equine Hospital in Hampshire. The one-hour webinar, which takes place at 8.00pm on Wednesday 10 April, will educate horse owners on how the veterinary profession's understanding of this debilitating and devastating disease has been completely revolutionised over the past five years. It will be followed by an interactive Q&A session when viewers will be able to pose questions for David to answer.
David said: "As our knowledge of the two hormonal diseases responsible for the majority of cases of laminitis improves, veterinary surgeons can offer their clients more comprehensive advice on treatment options to prevent laminitis. For many owners who have struggled with this condition, this is an absolute revelation and has enormous welfare benefits".
Horse owners can register to view the online programme by visiting www.talkaboutlaminitis.co.uk.
To ensure that veterinary surgeons are versed in the most up to date research available, Boehringer Ingelheim will also be hosting a webinar for veterinary professionals at 8.00pm on Wednesday 13th March, presented by Professor Andy Durham BSc BVSc CertEP DEIM DipECEIM MRCVS. The online seminar, 'The laminitis revolution.... An update on our understanding of endocrinopathic causes of laminitis', will entitle the viewer to a downloadable certificate for one hour of CPD. To register, visit www.bi-academy.co.uk. Places are limited, so register early to avoid disappointment. The webinar will also be available to view after the event on demand.
For further information on how you can promote 'Talk About Laminitis' in your practice contact your Boehringer Ingelheim Territory Manager or call 01344 746959
References
1. Karikoski et al. (2011). The prevalence of endocrinopathic laminitis among horses presented for laminitis at a first-opinion/referral equine hospital. Domestic Animal Endocrinology 41 111-117
2. Donaldson et al. (2004). Evaluation of suspected pituitary pars intermedia dysfunction in horses with laminitis. J Am Vet Med Assoc;224:1123-1127.
Vétoquinol, makers of Zylkène, a complementary feed for cats and dogs, has launched www.zylkenepet.co.uk, a new website with advice for pet owners about how they can help their pet deal with unsettling situations.
The website offers a behavioural quiz to help identify whether a pet may need help coping with any changes taking place. In addition, the site offers tips and advice from behavioural experts together with guides to helping pets cope with situations such as moving home, the introduction of a new baby or new people, travelling and holidays, coping with kennel and cattery stays and fireworks.
Krystyna Joyce, Product Manager at Vétoquinol, said: 'Owners often give Zylkène when their pet needs a bit of extra support to deal with unusual situations and changes to their routine, but there are also lots of practical things you can do that will improve a pet's experience further during that time. We wanted to make sure that information was readily available through a succinct, user friendly website.'
Researchers from the University of Bristol have published the results of a study which has identified risk factors for syringomyelia (SM) and which could help breeders select away from characteristics which predispose dogs to the disease.
Syringomyelia, which more commonly affects toy breeds such as the Cavalier King Charles Spaniel and the Chihuahua, causes fluid-filled cavities in the spinal cord. In these toy breeds, SM is usually secondary to a specific malformation of the skull called Chiari-like Malformation (CM).
The research looked at the relationship between head shape and the incidence of CM/SM. Dogs were measured in several countries using a standardised "bony landmark" measuring system and photos analysed by researchers.
The researchers found two significant risk factors associated with CM/SM in the skull shape of the CKCS: brachycephaly (the broadness of the top of skull relative to its length) and the distribution of doming of the skull. The study suggests that brachycephaly, with resulting doming towards the front of the head, is associated with CM/SM.
Thomas Mitchell, the undergraduate student who conducted the study under the supervision of Dr Clare Rusbridge, said: "Dog breeders are very experienced at selecting for a certain conformation or appearance in dogs. Our findings may allow breeders to select away from the condition over fewer generations by choosing appropriate matings and offspring to continue breeding programmes. The identification of an appearance that might protect against developing the disease is a significant step forward in tackling this painful condition.
"The study also provides guidance to breed clubs, breeders and judges that have a responsibility to avoid obvious conditions or exaggerations which would be harmful in any way to the health, welfare or soundness of the breed. It will also provide vets with verified advice to provide to breeders outside the show ring and to occasional hobbyists."
The study has been published online in the journal Canine Genetics and Epidemiology, and a video animation which shows the differences in head shape is available on YouTube.
The work was funded by a grant from the Kennel Club Charitable Trust and the Companion Cavalier Club provided a grant for the publication of the research.
Reference
In what is believed to be a first for the profession, a group of experts have joined forces to publish 'Chronic Pain in the Dog', a blog about managing pain.
The blog, which is sponsored by Vetoquinol and available exclusively to VetSurgeon.org members, offers opinions and advice from Dr Jo Murrell, BVSc PhD CertVA DipECVA MRCVS, Head of Anaesthesia at Bristol Vet School, Kate L White MA Vet MB DVA Dipl ECVAA MRCVS, European Specialist in Veterinary Anaesthesia & Analgesia, Associate Professor in Veterinary Anaesthesia and Clinical Sub Dean at Nottingham University Veterinary School and Krista Visser 't Hooft, DVM, DipACVIM (Internal Medicine), MRCVS, Specialist in Medicine.
A new blog entry is posted every few days, and each one focuses on just one aspect of pain management, to make it easy to digest in a busy day. The aim is to help build the clinician's understanding of the topic over time.
It is also hoped that the blog will build into a useful information resource, both to raise awareness of pain management and aid clinicians in making decisions about how to approach complex cases.
VetSurgeon members can subscribe to be alerted to new blog entries by email, and (at the time of writing) there is a prize of a £10 Amazon voucher for every 50th veterinary surgeon to do so.
Click here to read the blog and subscribe.
VetSurgeon member Viki Edmondson MRCVS is taking part in a drive to help 13-year-old Octavia Woodward, who was born with spinal muscular atrophy (SMA), raise £100,000 to help The SMA Trust.
Viki, a well-known vet in the carriage driving world, will be joining Octavia on 'Octavia's Mad Marathon', a five-day, 110 mile carriage drive from Windsor to Wincanton.
Octavia will be driving her pony, Diddy, with her mother Henrietta as co-driver. Meanwhile, Viki will be driving a pair of Gelderlander horses. They'll be leaving the main ring at the Royal Windsor Horse Show with a support crew at 3:30pm on 13th May.
Viki graduated from Bristol Veterinary School in 1993. Since 2001 she has run her own equine practice plus a small animal surgery from the Newdigate, Surrey farm she shares with husband Peter. Viki has known Octavia since she was born and it was Viki who paired up Diddy with Octavia and encouraged her to progress from walking round the roads to the excitement of "off-roading". Viki will be providing support and encouragement to Octavia during the trip - of course with any veterinary help being close by.
To support Viki and Octavia, visit: http://www.justgiving.com/vikithevet
The Animal Medicines Distributors Association (AHDA) and the Animal Medicines Training Regulatory Authority (AMTRA) have both come out against the BVA's call for all anthelmintic medicines to be reclassified as POM-V, which would prevent them being prescribed by Suitably Qualified Persons (SQP).
Ian Scott, Secretary General of AHDA, said that instead of launching an attack on SQPs, the BVA should be working with them and animal owners to tackle anthelmintic resistance: "The BVA has written to the VMD to ask that all anthemintics be classified to POM-V only. This will monopolise the supply and distribution of anthelmintics for vets only. It effectively places the blame for anthelmintic resistance squarely on SQPs.
"An attempt by BVA to create a division between vets and SQPs demonstrates that the BVA is out of touch with its members.
"Both prescribing channels must work together to tackle the problem and AHDA has been working hard with vets at national and local level to ensure customers receive consistent, high quality, up-to-date and relevant advice from both channels.
"What is worrying is that the BVA attack also infers that farmer producers and equine owners are incapable of making decisions that not only affect their livelihood but cast doubt on their ability to care for their animals' welfare."
Meanwhile, Stephen Dawson, Secretary General of AMTRA said: "The large majority of SQPs deal with parasite control on a daily basis, having trained and been examined to a syllabus developed with BVA input. SQPs have to undertake compulsory continuing professional development, the majority of which includes good practice in parasite control. Therefore AMTRA has every confidence that qualified SQPs have excellent knowledge of parasitology to advise their clients on the correct choice and use of anthelmintics.
"It is important to recognise the hard work, knowledge and dedication of thousands of SQPs throughout the UK. The implication of what BVA say is that they are laying a proportion of the blame for resistance to these medicines at the door of SQPs. But the evidence isn't there: countries in Europe and elsewhere with different prescription systems, mainly though vet-only channels, still have major resistance problems. Prescription of antimicrobials by veterinary surgeons hasn't prevented concerns about prescribing practices and developing resistance. The key point is good advice from the prescriber and how they are then used in practice, rather than who prescribes them. The challenge for us all is not just to seek excellence in prescribing but also in usage on farm, something SQPs are ideally placed to do with their frequent farmer contact.
"I would urge all parties to work in partnership to ensure that best practice in prescription and use is followed by all prescribers and users. It is up to all prescribers to act responsibly, but to single out one group over another is unjustified. A pseudo-monopoly by vets on supply would do nothing to help farmers in difficult times."
Mr Dawson also expressed doubts about permanent POM-V status for new livestock anthelmintics: "While we fully support VMD's and VPC's need to be sure that the risk associated with wider availability of a new product is low, AMTRA considers that the current division in distribution classes and consequent low uptake of the newer products means that the much bigger risk is that widespread reliance on the three aging classes may be followed by reliance on just the two new classes when the older classes become unusable. Much better to have responsible prescription of all five classes now, by appropriately trained SQPs, vets and pharmacists, to ensure that there is a prospect of long term availability of effective parasite control."
BVA Past President Peter Jones is appearing before an All Party Parliamentary Group (APPG) on Antibiotics today, to update parliamentarians and stakeholders on the efforts the association and the profession are making to tackle the issue. Speaking to the APPG, Peter will say: "We know that the biggest cause of antibiotic resistance in humans is the overuse and misuse of antibiotics in human medicine and this was highlighted in the joint report on resistance from the Department of Health (DoH) and Defra.
"However, we are not complacent about the role of antibiotic use in veterinary medicine and we are one of the leading voices in the campaign for the responsible use of antibiotics in all species.
"We remain committed to the One Health principle and the need for the medical and veterinary professions to work together to tackle antimicrobial resistance. BVA and our specialist divisions are currently working on a plan to deliver the five-year strategy on AMR from the veterinary perspective. The actions being taken have been published along with those of our partners in the RUMA response to the DoH/Defra strategy.
"One of our key aims for the strategy will be to promote the importance of evidence-based responsible use among both vets and their clients. We are already encouraging education on minimising resistance and principles of responsible use through engagement with the veterinary schools and other stakeholders, and through our own continuing professional development (CPD) programme.
"The use of antibiotics in veterinary medicine in Europe in the future may well be different to how we have used them in the past, with certain constraints on certain classes of critically important medicines used in man. We will cooperate in adapting to this new environment but any changes must be based on sound scientific risk analysis and not on misrepresentation of the evidence, or at worse falsification of that evidence."
Another key action for BVA is the updating of BVA's responsible use guidance for the veterinary profession, and BVA's species divisions continue to work on advice tailored to their particular sectors.
BVA is also continuing to call for quicker, cheaper and more accessible accurate sensitivity and pen-side testing for veterinary use, and repeated this call in recent submissions to the Science & Technology Select Committee and the APPG on Eggs, Pigs and Poultry.
BVA has also agreed in principle that antibiotic use should be recorded and reported and will consider how such recording and reporting may be encouraged, how usage may be measured and audited, and how prescribing habits can be assessed. Such measures will help us to monitor trends in resistance development and track the progress we can make in addressing the problem.
The Animal Health Trust is calling for all small animal practitioners to help with a prospective survey study on breed differences in clinical features in canine hyperadrenocorticism.
The Trust is asking vets that diagnose a case of spontaneous hyperadrenocorticism to complete an online questionnaire at bit.ly/aht-cushing.
The questionnaire should take 10 minutes to complete and all the information will be processed anonymously. Each questionnaire submitted has a chance to win a £100 Amazon voucher. On completing the survey, participants can ask to be notified of the results of this study when available.
Researchers say they hope this data will help veterinary surgeons in the diagnosis of canine hyperadrenocorticism, and ask that everyone helps spread the word about the study.
If you have any queries about this study, please contact michael.bennaim@aht.org.uk
Vetoquinol has announced that packs of Rubenal 300mg are now available in bottles of 60 tablets instead of the previous 20.
Rubenal, which was launched earlier this year, is a complementary nutritional feeding stuff for the support of renal function in case of chronic renal insufficiency in dogs and cats. It is used as an aid to the maintenance of the normal renal fibrous architecture.
Simon Boulton, Rubenal's product manager said: "This increased pack size is a direct result of customer consultation. It will make treatment more cost effective for dogs and allow a longer treatment period per pack purchased."
For further information please contact your Vetoquinol representative or telephone 0800 1698197.
81% of equine worming strategies are not effective in fight against resistance, because owners are not conducting an adequate level of faecal egg counts (FEC), according to a survey carried out by Countrywide, the supplier of equestrian products.
The company surveyed nearly 1,000 horse owners in collaboration with Westgate Laboratories, Norbrook and BW Equine Vets and found that 47% have never conducted an FEC test.
When asked about their current approach to worming, 59% of respondents said they worm at set times of the year with only 31% conducting regular FEC tests.
Mark Hawkins, SQP at Countrywide, said: "With worms becoming resistant to some worming drugs, simply dosing all horses with routine wormers is not adequate. A targeted approach, which considers each horse as an individual, is needed."
Gillian Booth owner at Westgate Laboratories said: "The results show that the majority of horse owners are not updating their worming practice to match the increase in resistance and improvement in testing technology. Previous worming practices have led to the resistance problems we now have so it is vital that there is change."
The survey found that veterinary surgeons and in store advisors are vital to promote change - 65% of respondents actively seek advice from their vet and Suitably Qualified Person (SQP) for worming and general health care.
Mark added: “A huge 99% of people worm their horse at least once a year; despite this 38% of horse owners do not know an accurate weight of their horse. Considering inaccurate dosing plays a large role with the increase in resistance this figure is very concerning. If you do need to treat, accurate dosing is essential.”
The survey found that 86% of respondents had wormed for tapeworm, making it the most wormed for parasite. Despite this, only 6% of horse owners had conducted a saliva test for tapeworm, and only 8% had conducted the more established ELISA blood test through their vet to prove the need for this worming dose.
For a full breakdown of the survey results, visit: www.countrywidefarmers.co.uk/wormingsurvey.